Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Empagliflozin (10mg) + Linagliptin (5mg) + Metformin (1000mg) Tablet
Therapeutic Category
Antidiabetic, Diabetic
Dosage Form
Tablet
Packaging Type
Alu Alu
Packaging
10*10
Price
₹1/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Some patients may experience nausea, diarrhea, increased urination, urinary tract infections, headache, or abdominal discomfort. Rarely, pancreatitis, dehydration, ketoacidosis, or lactic acidosis may occur and require immediate medical attention.
Emplozin LM 10 Tablet is indicated for type 2 diabetes mellitus in patients requiring combination therapy for improved glycemic control. It helps lower fasting and post-meal blood glucose levels, improve insulin utilization, and support long-term diabetes management.
This medicine should be used under medical supervision along with a healthy diet and regular exercise. Regular monitoring of blood glucose, kidney function, and hydration status is recommended. Avoid excessive alcohol intake during treatment.
Store in a cool, dry place below 25°C, protected from moisture and direct sunlight. Keep the tablets in their original packaging and out of reach of children.
Composition : Empagliflozin 25mg + Sitagliptin 100mg + Metformin 1000mg (extended release)
Composition : Empagliflozin (10mg) + Linagliptin (5mg)
Composition : Empagliflozin (25mg) + Linagliptin (5mg)
Composition : Empagliflozin (10mg) Tablet
Composition : Empagliflozin (12.5mg) + Metformin (1000mg)
Composition : Empagliflozin (12.5mg) + Metformin (500mg)
Composition : Empagliflozin (5mg) + Metformin (500mg)
Composition : Empagliflozin (10mg) + Sitagliptin 100mg
Composition : Empagliflozin (25mg) + Sitagliptin (100mg) Tablet
Composition : Empagliflozin (25mg) Tablet
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Emplozin LM 10 Tablet, containing Empagliflozin 10mg, Linagliptin 5mg, and Metformin 1000mg, has very strong demand in the antidiabetic segment, making it a high-value product for medical distributors, wholesalers, and pharma franchise partners focusing on advanced diabetes management portfolios.
Medical distributors and agencies can benefit from the growing demand for triple-combination oral antidiabetic therapy used in uncontrolled type 2 diabetes mellitus. Metformin reduces glucose production, Linagliptin improves insulin response, and Empagliflozin promotes glucose excretion through urine, strengthening a comprehensive diabetes care product portfolio.
Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Emplozin LM 10 Tablet with promotional support, monopoly rights, quality packaging, and competitive pricing for distributors and wholesalers.
Wholesalers and medical agencies benefit from high chronic prescription demand, strong diabetes market growth, long-term patient usage, reliable supply chain support, and good margins when partnering for Emplozin LM 10 Tablet distribution.
Medical distributors, stockists, and wholesalers interested in Emplozin LM 10 Tablet can contact Cafoli LifeCare Pvt Ltd to discuss franchise opportunities, bulk supply requirements, pricing, and distribution support.